The World Health Organization suspended procurement and supply of Covaxin, a Covid-19 vaccine made by Bharat Biotech International Ltd., citing issues following an inspection at the company’s ...

Ocugen Inc (NASDAQ: OCGN), India-based Bharat Biotech’s U.S. partner for COVID-19 vaccine Covaxin, has submitted a “Master File” to the FDA before seeking an emergency use authorization (EUA ...

Bharat Biotech has emphasised the need for more comprehensive data to ensure unbiased and informative safety evaluations. Several studies have reported rare side effects from AstraZeneca's vaccine ...

Bharat Biotech specializes in vaccine development. The novel Covid-19 vaccine was developed in the lab of Jefferson professor Matthias Schnell, an infectious disease expert.

Bharat Biotech will supply initial doses to be used in the U.S. upon Ocugen’s receipt of an EUA. In addition, Bharat Biotech will support the technology transfer for manufacturing in the U.S.

Bharat Biotech on target to reach a billion Covaxin doses With specialised bio safety containment facilities in Hyderabad, Malur, Ankleshwar, and Pune, Bharat Biotech said that it is steadily ...

Bharat Biotech announced the release of an oral cholera vaccine (OCV), a significant public health issue in regions with inadequate sanitation (1 Trusted Source Unique International Collaboration ...

Bharat Biotech in Hyderabad, India will then begin production scale-up for safety and efficacy testing in humans. CoroFlu could be in human clinical trials by the fall of 2020.

Bharat Biotech, government cash and partners in hand, aims for 700M COVID-19 shots per year By Fraiser Kansteiner Apr 20, 2021 9:39am coronavirus COVID-19 manufacturing expansion vaccine manufacturing ...

India's drug regulator on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to a Mint report ...

The partnership with Bharat Biotech will help Jefferson complete animal testing and rapidly move to a Phase 1 clinical trial, Schnell said. Bharat Biotech CEO Dr. Krishna Mohan said Jefferson’s ...